» Articles » PMID: 20335529

CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-derived Macrophages

Overview
Journal J Immunol
Date 2010 Mar 26
PMID 20335529
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

In atherosclerotic arteries, blood monocytes differentiate to macrophages in the presence of growth factors, such as macrophage colony-stimulation factor (M-CSF), and chemokines, such as platelet factor 4 (CXCL4). To compare the gene expression signature of CXCL4-induced macrophages with M-CSF-induced macrophages or macrophages polarized with IFN-gamma/LPS (M1) or IL-4 (M2), we cultured primary human peripheral blood monocytes for 6 d. mRNA expression was measured by Affymetrix gene chips, and differences were analyzed by local pooled error test, profile of complex functionality, and gene set enrichment analysis. Three hundred seventy-five genes were differentially expressed between M-CSF- and CXCL4-induced macrophages; 206 of them overexpressed in CXCL4 macrophages coding for genes implicated in the inflammatory/immune response, Ag processing and presentation, and lipid metabolism. CXCL4-induced macrophages overexpressed some M1 and M2 genes and the corresponding cytokines at the protein level; however, their transcriptome clustered with neither M1 nor M2 transcriptomes. They almost completely lost the ability to phagocytose zymosan beads. Genes linked to atherosclerosis were not consistently upregulated or downregulated. Scavenger receptors showed lower and cholesterol efflux transporters showed higher expression in CXCL4- than M-CSF-induced macrophages, resulting in lower low-density lipoprotein content. We conclude that CXCL4 induces a unique macrophage transcriptome distinct from known macrophage types, defining a new macrophage differentiation that we propose to call M4.

Citing Articles

The Role of mtDNA Mutations in Atherosclerosis: The Influence of Mitochondrial Dysfunction on Macrophage Polarization.

Fedotova E, Berezhnov A, Popov D, Shitikova E, Vinokurov A Int J Mol Sci. 2025; 26(3).

PMID: 39940788 PMC: 11817597. DOI: 10.3390/ijms26031019.


CA19-9-related macrophage polarization drives poor prognosis in HCC after immune checkpoint inhibitor treatment.

Du T, Zou J, Yang Y, Xie H, Pang H, Zhuang W Front Oncol. 2025; 14:1528138.

PMID: 39868376 PMC: 11757246. DOI: 10.3389/fonc.2024.1528138.


CXCL4 deficiency limits M4 macrophage infiltration and attenuates hyperoxia-induced lung injury.

Yu B, Jia S, Chen Y, Guan R, Chen S, Tang W Mol Med. 2024; 30(1):253.

PMID: 39707183 PMC: 11660834. DOI: 10.1186/s10020-024-01043-y.


Lung immune incompetency after mild peritoneal sepsis and its partial restoration by type 1 interferon: a mouse model study.

Meng Q, Seto F, Totsu T, Miyashita T, Wu S, Bougaki M Intensive Care Med Exp. 2024; 12(1):119.

PMID: 39707074 PMC: 11662124. DOI: 10.1186/s40635-024-00707-7.


Efferocytosis dysfunction in CXCL4-induced M4 macrophages: phenotypic insights in systemic sclerosis and .

Le Tallec E, Bellamri N, Lelong M, Morzadec C, Frenger Q, Ballerie A Front Immunol. 2024; 15:1468821.

PMID: 39464886 PMC: 11512447. DOI: 10.3389/fimmu.2024.1468821.


References
1.
Koenen R, von Hundelshausen P, Nesmelova I, Zernecke A, Liehn E, Sarabi A . Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med. 2009; 15(1):97-103. DOI: 10.1038/nm.1898. View

2.
Pitsilos S, Hunt J, Mohler E, Prabhakar A, Poncz M, Dawicki J . Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost. 2003; 90(6):1112-20. DOI: 10.1160/TH03-02-0069. View

3.
Gordon S . Macrophage heterogeneity and tissue lipids. J Clin Invest. 2007; 117(1):89-93. PMC: 1716225. DOI: 10.1172/JCI30992. View

4.
Gewirtz A, Calabretta B, Rucinski B, Niewiarowski S, Xu W . Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest. 1989; 83(5):1477-86. PMC: 303850. DOI: 10.1172/JCI114041. View

5.
Bouhlel M, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S . PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 2007; 6(2):137-43. DOI: 10.1016/j.cmet.2007.06.010. View